Emergency Use Authorizations of COVID-19-Related Medical Products

被引：15
作者：
Moshkovits, Itay [1 ,2 ]
Shepshelovich, Daniel [1 ,2 ]
机构：
[1] Tel Aviv Sourasky Med Ctr, Div Gen Med, Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
来源：
JAMA INTERNAL MEDICINE | 2022年 / 182卷 / 02期
关键词：
D O I：
10.1001/jamainternmed.2021.7257
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：228 / 229
页数：2
相关论文
共 6 条
  • [1] Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic.
    Rizk, John G.
    Forthal, Donald N.
    Kalantar-Zadeh, Kamyar
    Mehra, Mandeep R.
    Lavie, Carl J.
    Rizk, Youssef
    Pfeiffer, JoAnn P.
    Lewin, John C.
    [J]. DRUG DISCOVERY TODAY, 2021, 26 (02) : 593 - 603
  • [2] Misguided Use of Hydroxychloroquine for COVID-19 The Infusion of Politics Into Science
    Saag, Michael S.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (21): : 2161 - 2162
  • [3] Assessment of Data Sources That Support US Food and Drug Administration Medical Devices Safety Communications
    Tau, Noam
    Shepshelovich, Daniel
    [J]. JAMA INTERNAL MEDICINE, 2020, 180 (11) : 1420 - 1426
  • [4] US Food and Drug Administration, EM US AUTH
  • [5] False Negative Tests for SARS-CoV-2 Infection - Challenges and Implications
    Woloshin, Steven
    Patel, Neeraj
    Kesselheim, Aaron S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (06) : e38
  • [6] Need for Transparency and Reliable Evidence in Emergency Use Authorizations for Coronavirus Disease 2019 (COVID-19) Therapies
    Zhai, Mike Z.
    Lye, Carolyn T.
    Kesselheim, Aaron S.
    [J]. JAMA INTERNAL MEDICINE, 2020, 180 (09) : 1145 - 1146
1